To establish normal parameters, we have measured 14 proteins in 120 amniotic fluid samples from normal second trimester pregnancies. Pregnancy-associated macroglobulin (PAM), identified in 1 5 samples, has sewed to indicate contamination with maternal blood; this represents the first time that PAM has been used for this purpose. Albumin, transferrin, a-1-antitrypsin, orosomucoid, IgG, and C3 show great variability in individual concentrations but are. generally in proportion to each other, particularly transferrinlalbumin, a-1-antitrypsin/albumin, and IgGlalbumin. The fust two ratios are similar to proportions in adult serum, supporting the concept that most amniotic fluid protein is maternal in origin and moves directly across the amnionic membrane. Levels of low density lipoproteine, C4, IgA, IgM, a-2-macroglobulin, and haptoglobin, all low in amniotic fluid, vary independently both of albumin and of each other. a-1-letoprotein levels are normal in aU samples, suggesting freedom from gross fetal blood contamination. In the presence of maternal blood contamination, 1 0 of the 1 5 samples show clear elevation of at least one protein level; C3, IgA, and a-2-macroglobulin are most frequently abnormal.
Summary
To establish normal parameters, we have measured 14 proteins in 120 amniotic fluid samples from normal second trimester pregnancies. Pregnancy-associated macroglobulin (PAM), identified in 1 5 samples, has sewed to indicate contamination with maternal blood; this represents the first time that PAM has been used for this purpose. Albumin, transferrin, a-1-antitrypsin, orosomucoid, IgG, and C3 show great variability in individual concentrations but are. generally in proportion to each other, particularly transferrinlalbumin, a-1-antitrypsin/albumin, and IgGlalbumin. The fust two ratios are similar to proportions in adult serum, supporting the concept that most amniotic fluid protein is maternal in origin and moves directly across the amnionic membrane. Levels of low density lipoproteine, C4, IgA, IgM, a-2-macroglobulin, and haptoglobin, all low in amniotic fluid, vary independently both of albumin and of each other. a-1-letoprotein levels are normal in aU samples, suggesting freedom from gross fetal blood contamination. In the presence of maternal blood contamination, 1 0 of the 1 5 samples show clear elevation of at least one protein level; C3, IgA, and a-2-macroglobulin are most frequently abnormal.
Similar-protein analyses have also been carried out on 11 samples from pregnancies with anencephaly, 5 with spina bifida, and 3 with fetal demise. Results have been compared with normal and blood-contaminated samples. Most protein concentrations are either high normal or abnormally elevated with anencephaly and fetal demise but not with spina bifida. Of aU proteins studied, low density lipoprotein is most reliably elevated with neural tube defects and demise and is least affected by blood contamination. IgM and a-2-macroglobulin are also elevated in a significant percentage of uncontaminated samples. Increased IgA and haptoglobin levels correlate with blood contamination but not with neural tube defects. Low density lipoprotein, IgM, and a-2-macroglobulin may be useful adjuncts in the second trimester prenatal diagnosis of neural tube defects.
Speculation
Well defined normal ranges for second trimester amniotic,, fluid proteins are a prerequisite for.applying such measurements to diagnosing fetal dysfunction and understanding transamniotic interactions between mother and fetus. In defining such parameters, the present study first re-enforces the necessity to identify blood contamination and then establishes low density lipoprotein, IgM, and a-2-macroglobulin measurements as potentially useful ancillary studies for the prenatal diagnosis of neural tube defects. Similar testing on samples associated with omphalocele, congenital nephrosis, esophageal atresia,'and other major fetal malformations must be carried out to determine whether these measurements may be of further help in second trimester differential diagnosis.
Ultrasound techniques, already widely used as an adjunct to amniocentesis, can detect anencephaly with little difficulty (3). Amniography, currently used on a more limited basis, also can detect anencephaly but until recently has shown little promise of delineating other AFP-related lesions (12). MaCri and Weiss 131) have now documented the first actual visualization o f meningomyelocele by amniography, and it is likely that this technique will find increasing application in the near future. Using a different approach,-~osden and Brock have recently reported on the use o f amniotic fluid macrophage analysis to distinguish between NTD, omphalocele, and normal fetuses (17) .
Once confirmed, this will represent still another adjunctive technique to apply to AFP-positive second trimester amniotic fluid.
Several preliminary reports have indicated that other amniotic fluid proteins (besides AFP) may be elevated during the second trimester in the presence of an NTD (4,5,20), suggesting that such testing may also be an aid to more accurate and ,reliable diagnosis of fetal malformations.
Unlike AFP, which is specifically manufactured by the fetus, most other amniotic fluid proteins are found both in maternal and fetal circulations (14.15).
Hence, to be of diagnostic significance, such proteins must be characterized not only by their concentrations, but also by their maternal and fetal contributions.
Already, several major amniotic fluid proteins have been shown to be largely of maternal origin, thus dimming prospects of their diagnostic value' (21,28,29).
As a further complication, amniotic fluid samples are sometimes contaminated with maternal blood, distorting measurements and making them less reliable (4). Also, some amniotic fluid protein concentrations vary with gestational age (29).
We attempt, in this paper, first to define normal ranges for 12 amniotic fluid proteins during the second trimester identifying maternal blood contamination by measuring pregnancy-associated macroglobulin (PAM) (1). a protein ordinarily found only in maternal serum and not previously used for this purpose. AFP has also been measured in all samples; in this case to exclude gross fetal blood contamination.
Next, we examine amniotic fluid samples obtained from second trimester pregnancies known to be affected with neural tube defects and fetal demise. These measurements are then compared with the normal and bloodcontaminated samples as a first step towards learning whether such measurements may be helpful in the differential diagnosis of in ut'ero congenital malformations.
MATERIALS AND METHODS
Amniotic Fluid Samples -These were frozen after collection and were from pregnancies whose subsequent outcome was known. Gestational dating was calculated from the last menstrual period (LMP) and was, inlmost cases, confirmed by ultrasound and/or delivery date.
Sample identity was by coded numbers, and informed consent was obtained in each case.
A total of 120 specimens, from between 14 and 22 weeks gestation, were analyzed. Before testing, each sample was centrifuged at 2,500 rpm for 15 minutes.
Assay of Proteins -Analyses were carried out in the Technicon
Automated Immunopreci'pitin System (261, using antisera from Atlantic Antibodies, Inc. (Westbrook, Maine).
Antisera were diluted individually in 4% polyethylene glycol for each experiment and were then put through a millipore filter. Antigen controls were prepared from a serum pool whose protein values were known, and a 5 point standard curve, prepared from a reference material, was run each day for every protein. Controls were inserted after every twelfth sample.
Most samples were tested undiluted, but dilutions as high as 1:32 were required occasionally when antigen concentrations or blanks were high. For a given sample, all 12 proteins were analyzed on the same day.
Prior to each set of measurements, diluted antiserum was pumped through the analyzer for several minutes to establish a baseline. A setting of 500 FSR was used for all blank determinations using amniotic fluid at a flow rate of 0.1 ml/min. Antibody dilutions varied with potency.
For actual measurements, amniotic fluid was sampled at a rate of 0.03 to 0.1 ml/min. In this system, amniotic fluid protein concentrations could be measured with confidence at between 0.2 and 3.0 mg/l, depending upon the protein being studied. The 105 samples with undetectable PAM levels have been assayed to determine the "normal" ranges for 12 proteins. Figure 1 shows the actual distribution of concentrations within normal range for each of the 12 proteins, most demonstrating considerably more variability than their serum counterparts.
Albumin, for example, ranges between 330 to 6400 mg/l.
For several of the proteins studied, a number of values fall below the limits of assav sensitivitv. and accurate depictions o f their distributionseare not posiible except at the upper end of their concentration ranges. Of the three, alpha 1-antitrypsin's ratio to albumin is the most similar between fetal serum, amniotic fluid and maternal serum.
None of the lower 6 proteins listed in Table 1 shows any tendency to vary either in proportion to albumin or to each other, and so no ratios are included for them.
Albumin and alpha-fetoprotein concentrations have been compared in amniotic fluid samples for each of the weeks under study to determine whether a direct or inverse relationship exists. The two proteins have been found to vary randomly and independently.
The 15 amniotic fluid samples with measurable levels of PAM have been analyzed separately on the assumption that they are contaminated with maternal blood. Table 2 Sensitivity of this method is equivalent to, and in some cases greater than, the Laurell electroimmunoassay. Nephelometry is more sensitive than radial immunodiffusion, the method most often used in published studies of amniotic fluid proteins.
For six of the proteins analyzed here, the entire normal range is measurable, but for the remainder, a significant number of samples has values below assay detection. More sensitive methods must be applied to these before they can be fully examined.
Those proteins which can be satisfactorily measured have a wide range of normal.
In this respect, normal amniotic fluid differs from other body fluid compartments.
Maternal blood contamination has been identified in 12% of our samples by testing for a pregnancy-associated macroglobulin, found in maternal but not in fetal serum; a percentage in reasonable agreement with published figures from other series (4) . Since this marker has not been used previously, and since information on the original characteristics of the samples is not available, it has not been possible to correlate PAM levels and the actual degree of contamination. Most PAM positive samples have higher than normal protein values, showing sufficient distortion of concentrations that meaningful interpretati~ns cannot be made except for fetally derived proteins such as AFP. For evaluating possible maternal blood contamination in samples received after centrifugation, PAM should prove a more reliable indicator than hemoglobin A whose presence depends upon hemolysis. A number of our PAM positive samples have elevated alpha 2-macroglobulin conceetrations, an important consideration when that protein is being tested along with AFP in neural tube defect detection (4) .
Most amniotic fluid proteins appear to be of maternal origin, and their passage across the amnion is governed by molecular size and configuration (28, 29) .
Disagreement exists as to the reason for amniotic membrane selectivity (3):
While not resolving that question, the present study does add information on relative protein proportions on the two sides of the membrane. On the amniotic fluid side, several, including transferrin, alpha 1-antitrypsin, orosomucoid, IgG and C3 vary in direct proportion to the amniotic fluid albumin concentration, suggesting that all are similarly regulated. Two of them, transferrin and alpha 1-antitrypsin, have ratios to albumin in amniotic fluid nearly identical to respective ratios in the adult serum, indicating even greater similarity in transmembrane movement.
Low density lipoprotein, C4, IgA, IgM, alpha 2-macroglobulin and haptoglobin all exist in unfavorable proportion to their serum counterparts; and none of them shows any tendency to vary proportionally with amniotic fluid albumin levels. This lack of correlation might be due to poor assay precision in the lower part of their normal ranges.
These proteins might be expected to increase most noticeably with maternal blood contamination but, in fact, they do not.
Fetal blood contamination is known to occur only occasionally (approximately 1 in 100 samples).
All samples in this study have normal AFP levels, making gross contamination with fetal serum unlikely. AFP is analogous to PAM in that it is specific to one circulatory system. It cannot be used prospectively as an indicator of fetal blood, however, since the prime purpose for its analysis is to link increased levels to neural tube defects.
In fact, fetal bleeding must be carefully excluded when interpreting AFP levels to avoid false positive results. Analysis of hemoglobin F, although helpful at times, is not reliable due to its dependence on hemolysis for identification. For diagnostic purposes it is desirable to have an uncentrifuged sample, so that red blood cells may be assessed quantitatively and for type of hemoglobin. Such samples were not available for the present study.
Because alpha-fetoprotein's structure is so similar to that of albumin (271, it would be reasonable to assume that both are handled similarly by the amniotic membrane (3). Since amniotic fluid AFP is fetal in origin and amniotic fluid albumin is maternally derived, concentrations of the two in amniotic fluid might possibly be reciprocally related as an expression of their equilibration across a bidirectional membrane. Attempts to demonstrate such a relationship in this study have been unsuccessful.
When compared with maternal blood-contaminated (PAM+) amniotic fluid samples, values from anencephalic (PAM-) pregnancies have a number of similarities but several important differences. Albumin, transferrin, alpha 1-antitrypsin, orosomucoid, IgG, and C3 follow similar patterns for both groups, although C3 is sometimes abnormally high in the PAM+ samples even when the rest are normal. C4 is out of the normal range only once in each group, while alpha 2-macroglobulin and IgM are abnormally high is a significant proportion from both groups. Three proteins behave discordantly in the two sample groups. IgA, elevated in half of the PAM+ normal samples, is always normal in the anencephalic group. Haptoglobin ranges from high-normal to elevated in the blood-contaminated specimens but is always lownormal with anencephaly.
Low density lipoprotein, normal in all but one of the PAM+ samples, is abnormal in 9 of the 11 specimens from anencephalic pregnancies.
With the exception of a few shared parameters, amniotic fluid results from meningomyelocele pregnancies are different from both of the preceding groups. The overall pattern of protein concentrations is lower, with abnormal values found only for low density lipoprotein (3/5), alpha 2-macroglobulin (2/5), and IgM (1/5).
These 3 proteins are also consistently abnormal in anencephalic pregnancies; the latter 2 being frequently elevated also with maternal blood-contamination. The spina bifida samples, like those from anencephalic pregnancies, have lownormal IgA and haptoglobin values in contrast to those contaminated with maternal blood.
Due to their turbidity and discoloration, the fetal demise samples may be identified by inspection.
Most protein concentrations in these samples are either high normal or actually elevated. Like samples from anencephaly, low density lipoprotein, IgM, and alpha 2-macroglobulin all are elevated, while C4, IgA and haptoglobin are consistently low.
Higa et a1 (20) have studied total protein and 28 individual proteins in 8 samples from cases of anencephaly (31-42 weeks gestation) and 5 from fetal demise (28-39 weeks gestation). His report observes that total protein, IgM, IgA, and IgG (as well as AFP) appear to be useful in diagnosing anencephaly and intrauterine fetal death. Our own results support IgM as being elevated in the majority of anencephalic cases; IgG only when associated with total protein increases; and IgA not at all. Discrepancies may be explained by the different stages of gestation at which the two studies have been carried out.
Measurement of albumin, IgA, IgG, IgM, AFP, and alpha 2-macroglobulin have been carried out by Cantuaria and Jones (9) on 2 meningomyelocele and 9 control amniotic fluid samples obtained during the second trimester.
In this study, only IgM elevations are associated with meningomyelocele, a finding at least partially consistent with the present report. It is not surprising that he has not found alpha 2-macroglobulin in his analyses, since the technique of radial immunodiffusion would not be expected to. be sensitive enough to measure the usual amniotic fluid concentration of that protein.
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In another study, Brock (4), using a "rocket" teahnique, has demonstrated consistently elevated alpha 2-macroglobulin values in 33 pregnancies associated with spina bifida or anencephaly from between 8 and 42 weeks gestation. Analyses of beta lipoprotein and IgM have been carried out as part of the same study, yielding the conclusion that they, too, are elevated in the presence of NTD. Brock emphasizes the possible distortion of results by maternal blood-contamination.
'This problem of amniotic fluid sample contamination by maternal blood is critical, since no observations can be made confidently on protein concentrations until that possibility has been taken into account. Information on original sample characteristics is often either unavailable or unreliable, and it is this fact which has led us to make use of pregnancy-associated macroglobulin to help identify maternal blood-contamination. The present study also suggests that any second trimester amniotic fluid sample having increased amounts of IgA or haptoglobin should be suspect as blood-contaminated, since neither NTD nor fetal demise samples show these abnormalities.
Low density lipoprotein appears to be the most diagnostically useful amniotic fluid protein for the second trimester diagnosis of NTD and fetal demise excluding, or course, AFP. It is normal in most blood-contaminated samples, an observation for which we have no ready explanation.
IgM and alpha 2-macroglobulin are also diagnostically useful, after exclusion of blood-contamination. Although neither is elevated in NTD cases as often as low density lipoprotein, measurement of all 3 proteins may be useful in an amniotic fluid sample with an elevated AFP value. Other amniotic fluid proteins measured in this study may be helpful in understanding the amniotic fluid dynamics both of normal and abnormal pregnancies but do not appear useful for pre-natal diagnosis of neural tube defects. -99th percentile by 'test f i t " analysis. Pregnancy-assxiated nracroglobulin mt present i n any of t h e 5 samples.
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